Report Summary
Eternity Insights has published a new study on Global Contrast Media/Contrast Agents Market focusing on key segments as by Type (Iodinated, Gadolinium-Based, Barium-Based, Other), by Application (Cardiology, Oncology, Neurology, Others), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Contrast Media/Contrast Agents Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Contrast Media/Contrast Agents Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Contrast Media/Contrast Agents Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Contrast Media/Contrast Agents Market Segmentation:
Contrast Media/Contrast Agents Market, By Type
- Iodinated
- Gadolinium-Based
- Barium-Based
- Other
Contrast Media/Contrast Agents Market, By Application
- Cardiology
- Oncology
- Neurology
- Others
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Contrast Media/Contrast Agents market in terms of demand generation. The Contrast Media/Contrast Agents market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Contrast Media/Contrast Agents market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Contrast Media/Contrast Agents Market Taxonomy:
To learn more about this report
Global Contrast Media/Contrast Agents Market Competitive Landscape
The global Contrast Media/Contrast Agents market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Guerbet Group
- Bayer Healthcare
- Bracco Diagnostic
- Covidien
- GE Healthcare
- Eli Lilly
- Alseres Pharmaceuticals
- Aposense
- Yangtze River Pharmaceutical
- Jiangsu Hengrui Medicine
- Shanghai Xudong Haipu Pharmaceutical
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Iodinated, Gadolinium-Based, Barium-Based, Other |
| By Application Outlook |
Cardiology, Oncology, Neurology, Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Guerbet Group, Bayer Healthcare, Bracco Diagnostic, Covidien, GE Healthcare, Eli Lilly, Alseres Pharmaceuticals, Aposense, Yangtze River Pharmaceutical, Jiangsu Hengrui Medicine, Shanghai Xudong Haipu Pharmaceutical |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Contrast Media/Contrast Agents Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Contrast Media/Contrast Agents Market Size Growth Rate by Product
1.4.2 Iodinated
1.4.3 Gadolinium-Based
1.4.4 Barium-Based
1.5 Market by End User
1.5.1 Global Contrast Media/Contrast Agents Market Size Growth Rate by End User
1.5.2 Cardiology
1.5.3 Oncology
1.5.4 Neurology
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Contrast Media/Contrast Agents Market Size
2.1.1 Global Contrast Media/Contrast Agents Revenue 2017-2027
2.1.2 Global Contrast Media/Contrast Agents Sales 2017-2027
2.2 Contrast Media/Contrast Agents Growth Rate by Regions
2.2.1 Global Contrast Media/Contrast Agents Sales by Regions
2.2.2 Global Contrast Media/Contrast Agents Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Contrast Media/Contrast Agents Sales by Manufacturers
3.1.1 Contrast Media/Contrast Agents Sales by Manufacturers
3.1.2 Contrast Media/Contrast Agents Sales Market Share by Manufacturers
3.1.3 Global Contrast Media/Contrast Agents Market Concentration Ratio (CR5 and HHI)
3.2 Contrast Media/Contrast Agents Revenue by Manufacturers
3.2.1 Contrast Media/Contrast Agents Revenue by Manufacturers (2017-2020)
3.2.2 Contrast Media/Contrast Agents Revenue Share by Manufacturers (2017-2020)
3.3 Contrast Media/Contrast Agents Price by Manufacturers
3.4 Contrast Media/Contrast Agents Manufacturing Base Distribution, Product Types
3.4.1 Contrast Media/Contrast Agents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Contrast Media/Contrast Agents Product Type
3.4.3 Date of International Manufacturers Enter into Contrast Media/Contrast Agents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Contrast Media/Contrast Agents Sales by Product
4.2 Global Contrast Media/Contrast Agents Revenue by Product
4.3 Contrast Media/Contrast Agents Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Contrast Media/Contrast Agents Breakdown Data by End User
6 North America
6.1 North America Contrast Media/Contrast Agents by Countries
6.1.1 North America Contrast Media/Contrast Agents Sales by Countries
6.1.2 North America Contrast Media/Contrast Agents Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Contrast Media/Contrast Agents by Product
6.3 North America Contrast Media/Contrast Agents by End User
7 Europe
7.1 Europe Contrast Media/Contrast Agents by Countries
7.1.1 Europe Contrast Media/Contrast Agents Sales by Countries
7.1.2 Europe Contrast Media/Contrast Agents Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Contrast Media/Contrast Agents by Product
7.3 Europe Contrast Media/Contrast Agents by End User
8 Asia Pacific
8.1 Asia Pacific Contrast Media/Contrast Agents by Countries
8.1.1 Asia Pacific Contrast Media/Contrast Agents Sales by Countries
8.1.2 Asia Pacific Contrast Media/Contrast Agents Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Contrast Media/Contrast Agents by Product
8.3 Asia Pacific Contrast Media/Contrast Agents by End User
9 Central & South America
9.1 Central & South America Contrast Media/Contrast Agents by Countries
9.1.1 Central & South America Contrast Media/Contrast Agents Sales by Countries
9.1.2 Central & South America Contrast Media/Contrast Agents Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Contrast Media/Contrast Agents by Product
9.3 Central & South America Contrast Media/Contrast Agents by End User
10 Middle East and Africa
10.1 Middle East and Africa Contrast Media/Contrast Agents by Countries
10.1.1 Middle East and Africa Contrast Media/Contrast Agents Sales by Countries
10.1.2 Middle East and Africa Contrast Media/Contrast Agents Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Contrast Media/Contrast Agents by Product
10.3 Middle East and Africa Contrast Media/Contrast Agents by End User
11 Company Profiles
11.1 Guerbet Group
11.1.1 Guerbet Group Company Details
11.1.2 Company Business Overview
11.1.3 Guerbet Group Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Guerbet Group Contrast Media/Contrast Agents Products Offered
11.1.5 Guerbet Group Recent Development
11.2 Bayer Healthcare
11.2.1 Bayer Healthcare Company Details
11.2.2 Company Business Overview
11.2.3 Bayer Healthcare Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Bayer Healthcare Contrast Media/Contrast Agents Products Offered
11.2.5 Bayer Healthcare Recent Development
11.3 Bracco Diagnostic
11.3.1 Bracco Diagnostic Company Details
11.3.2 Company Business Overview
11.3.3 Bracco Diagnostic Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Bracco Diagnostic Contrast Media/Contrast Agents Products Offered
11.3.5 Bracco Diagnostic Recent Development
11.4 Covidien
11.4.1 Covidien Company Details
11.4.2 Company Business Overview
11.4.3 Covidien Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Covidien Contrast Media/Contrast Agents Products Offered
11.4.5 Covidien Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 Company Business Overview
11.5.3 GE Healthcare Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2017-2020)
11.5.4 GE Healthcare Contrast Media/Contrast Agents Products Offered
11.5.5 GE Healthcare Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Company Business Overview
11.6.3 Eli Lilly Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Eli Lilly Contrast Media/Contrast Agents Products Offered
11.6.5 Eli Lilly Recent Development
11.7 Alseres Pharmaceuticals
11.7.1 Alseres Pharmaceuticals Company Details
11.7.2 Company Business Overview
11.7.3 Alseres Pharmaceuticals Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Alseres Pharmaceuticals Contrast Media/Contrast Agents Products Offered
11.7.5 Alseres Pharmaceuticals Recent Development
11.8 Aposense
11.8.1 Aposense Company Details
11.8.2 Company Business Overview
11.8.3 Aposense Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Aposense Contrast Media/Contrast Agents Products Offered
11.8.5 Aposense Recent Development
11.9 Yangtze River Pharmaceutical
11.9.1 Yangtze River Pharmaceutical Company Details
11.9.2 Company Business Overview
11.9.3 Yangtze River Pharmaceutical Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Yangtze River Pharmaceutical Contrast Media/Contrast Agents Products Offered
11.9.5 Yangtze River Pharmaceutical Recent Development
11.10 Jiangsu Hengrui Medicine
11.10.1 Jiangsu Hengrui Medicine Company Details
11.10.2 Company Business Overview
11.10.3 Jiangsu Hengrui Medicine Contrast Media/Contrast Agents Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Jiangsu Hengrui Medicine Contrast Media/Contrast Agents Products Offered
11.10.5 Jiangsu Hengrui Medicine Recent Development
11.11 Shanghai Xudong Haipu Pharmaceutical
12 Future Forecast
12.1 Contrast Media/Contrast Agents Market Forecast by Regions
12.1.1 Global Contrast Media/Contrast Agents Sales Forecast by Regions 2019-2025
12.1.2 Global Contrast Media/Contrast Agents Revenue Forecast by Regions 2019-2025
12.2 Contrast Media/Contrast Agents Market Forecast by Product
12.2.1 Global Contrast Media/Contrast Agents Sales Forecast by Product 2019-2025
12.2.2 Global Contrast Media/Contrast Agents Revenue Forecast by Product 2019-2025
12.3 Contrast Media/Contrast Agents Market Forecast by End User
12.4 North America Contrast Media/Contrast Agents Forecast
12.5 Europe Contrast Media/Contrast Agents Forecast
12.6 Asia Pacific Contrast Media/Contrast Agents Forecast
12.7 Central & South America Contrast Media/Contrast Agents Forecast
12.8 Middle East and Africa Contrast Media/Contrast Agents Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Contrast Media/Contrast Agents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
